At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine ...

At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m (1) TP).

At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹?TP). The ...

With the US poised to lose its measles-free status, an expert from GeoVax discusses how to win back the minds of Americans.

A new cancer therapy wakes up immune cells inside tumors and turns them against cancer.

Benefits seen from embracing platform technologies, combined with the role such systems played during the pandemic, are key dynamics.

KAIST researchers have developed an innovative treatment that transforms immune cells within tumours into cancer-fighting ...

HOLX launches Ultimate Defense, a new U.S. campaign that urges routine Pap + HPV screening to boost awareness and help curb ...

The Commerce Department is floating a proposal that would impede the commercialization of university researchers’ most ...

AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 15 that its research and development of the iterative process high-efficiency diploid rabies vaccine has successfully ...